The store will not work correctly when cookies are disabled.
[((3S)-3-Amino-3-carboxy)propyl][(4-hydroxy-3-nitrophenyl)methyl]phosphinic Acid
ID: ALA4082813
PubChem CID: 137646034
Max Phase: Preclinical
Molecular Formula: C11H15N2O7P
Molecular Weight: 318.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N[C@@H](CCP(=O)(O)Cc1ccc(O)c([N+](=O)[O-])c1)C(=O)O
Standard InChI: InChI=1S/C11H15N2O7P/c12-8(11(15)16)3-4-21(19,20)6-7-1-2-10(14)9(5-7)13(17)18/h1-2,5,8,14H,3-4,6,12H2,(H,15,16)(H,19,20)/t8-/m0/s1
Standard InChI Key: ZJMMIQORYZRSFH-QMMMGPOBSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
7.0809 -6.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0798 -6.8989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7878 -7.3079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4975 -6.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4946 -6.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7860 -5.6705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3731 -5.6709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6655 -6.0797 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
4.9577 -5.6713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2501 -6.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5423 -5.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8347 -6.0804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5421 -4.8544 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1268 -5.6720 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8349 -6.8976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6584 -5.2622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6584 -6.8966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2008 -5.6645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9100 -6.0704 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1977 -4.8473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2058 -7.3059 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 1 1
12 14 1 0
12 15 2 0
8 16 2 0
8 17 1 0
5 18 1 0
18 19 1 0
18 20 2 0
4 21 1 0
M CHG 2 18 1 19 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 318.22 | Molecular Weight (Monoisotopic): 318.0617 | AlogP: 0.87 | #Rotatable Bonds: 7 |
Polar Surface Area: 163.99 | Molecular Species: ZWITTERION | HBA: 6 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.32 | CX Basic pKa: 9.53 | CX LogP: -2.38 | CX LogD: -5.97 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.33 | Np Likeness Score: 0.15 |
References
1. Selvam C, Lemasson IA, Brabet I, Oueslati N, Karaman B, Cabaye A, Tora AS, Commare B, Courtiol T, Cesarini S, McCort-Tranchepain I, Rigault D, Mony L, Bessiron T, McLean H, Leroux FR, Colobert F, Daniel H, Goupil-Lamy A, Bertrand HO, Goudet C, Pin JP, Acher FC.. (2018) Increased Potency and Selectivity for Group III Metabotropic Glutamate Receptor Agonists Binding at Dual sites., 61 (5): [PMID:29397723] [10.1021/acs.jmedchem.7b01438] |